1. Controlled attenuation parameters to assess liver steatosis in obese patients with polycystic ovary syndrome
   Dongxu Wang et al, 2023, Frontiers in Endocrinology CrossRef
2. Polycystic ovary syndrome: approach to correction of metabolic disorders
   null Л. В. Калугіна et al, 2020, REPRODUCTIVE ENDOCRINOLOGY CrossRef
3. Polycystic Ovary Syndrome and Metabolic Syndrome: Clinical and Laboratory Findings and Non-Alcoholic Fatty Liver Disease Assessed by Elastography
   Claruza Braga Holanda Lavor et al, 2022, Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics CrossRef
4. Evaluation of Lipids and Lipid-Related Transcripts in Human and Ovine Theca Cells and an in Vitro Mouse Model Exposed to the Obesogen Chemical Tributyltin
   Natalia Pascuali et al, 2024, Environmental Health Perspectives CrossRef
5. Initial insight into three modes of data sharing: Prevalence of primary reuse, data integration and dataset release in research articles
   Yukiko Sakai et al, 2023, Learned Publishing CrossRef
6. NAFLD in Polycystic Ovary Syndrome: Association with PNPLA3 and Metabolic Features
   Amanda Medeiros Recuero et al, 2022, Biomedicines CrossRef
7. Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome
   Dongxu Wang et al, 2022, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy CrossRef
8. Dietary Glycotoxins, Advanced Glycation End Products, Inhibit Cell Proliferation and Progesterone Secretion in Ovarian Granulosa Cells and Mimic PCOS-like Symptoms
   null Lin et al, 2019, Biomolecules CrossRef
9. Activation of Insulin Signaling in Adipocytes and Myotubes by Sarcopoterium Spinosum Extract
   Michaella Ben-Shachar et al, 2019, Nutrients CrossRef
10. Abdominal Obesity as a Predictive Factor of Nonalcoholic Fatty Liver Disease Assessed by Ultrasonography and Transient Elastography in Polycystic Ovary Syndrome and Healthy Women
    Siriluk Tantanavipas et al, 2019, BioMed Research International CrossRef